Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The largest 24-week oral trial did not show enough benefit compared with placebo
S2CID 1509549
The absence of serious adverse events across varied doses, administration routes, and treatment durations represents a key safety finding that distinguishes AOD-9604s clinical profile
News Release April 03, 2002 More than one in five weight loss, slimming and/or diabetes supplements fail ConsumerLab.com evaluation Problems found in chromium and pyruvate products
US$ 29.78
US$ 25.40
US$ 26.17
US$ 25.44
US$ 29.41
